In the past few years, the genetic contribution to Parkinson's disease
(PD) has gained major attention and has resulted in the identificatio
n of the first mutant gene, called alpha-synuclein, involved in the pa
thogenesis of autosomal-dominant PD.alpha-Synuclein is a major compone
nt of Lewy bodies, which are a neuropathological feature of PD, furthe
rmore, deletions in the parkin gene have been identified as the primar
y cause in rare forms of autosomal-recessive juvenile PD.The elucidati
on of polygenic changes in the dopamine pathway, mitochondrial dysfunc
tion, and metabolism of xenobiotics is now technically possible by mea
ns of association and genotype studies.The increasing knowledge of the
pathogenesis of PD at a molecular level will have important implicati
ons for the development of individual therapeutic strategies to preven
t disease progression.